We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Burning Rock Biotech Ltd. entered a collaboration with IMPACT Therapeutics to provide testing services for IMPACT’s development of its ATR inhibitor IMP9064, which received IND clearance...